DTRA

HDTRA125S0001 Topics Release Final Amendment 4 The Defense Threat Reduction Agency (DTRA), through its Research and Development (RD) Directorate and Chemical and Biological Technologies Department, has released Amendment 4 to its Broad Agency Announcement (BAA) titled Fundamental Research to Counter Weapons of Mass Destruction (C-WMD). This long-term funding vehicle reflects DTRA’s sustained commitment to advancing […]

Advancing Countermeasures for Marine Toxin Threats The Defense Threat Reduction Agency (DTRA), through its Research and Development Chemical and Biological Technologies Directorate in support of the Joint Science and Technology Office (JSTO), has issued a Request for Information (RFI) titled “Plume”. This initiative seeks information on the capabilities and availability of suitable animal models for

Reimagining the Next Generation of Biodefense Vaccines: DTRA’s RAVEN Opportunity The Defense Threat Reduction Agency (DTRA), through its Joint Science and Technology Office (JSTO) and the Research and Development-Chem/Bio Medical Vaccines (RD-CBMV) division, has launched the Reimagining Available Vaccines and Envisioning Novelty (RAVEN) initiative. This forward-looking program is designed to modernize the nation’s medical countermeasure